These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16231621)

  • 1. A clinical, renal and immunological assessment of surface modifying additive treated (SMART) cardiopulmonary bypass circuits.
    Allen S; McBride WT; Young IS; MacGowan SW; McMurray TJ; Prabhu S; Penugonda SP; Armstrong MA
    Perfusion; 2005 Sep; 20(5):255-62. PubMed ID: 16231621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
    Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
    Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
    Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
    Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
    Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
    Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do surface-modifying additive circuits reduce the rate of cerebral microemboli during cardiopulmonary bypass?
    Rodriguez RA; Watson MI; Nathan HJ; Rubens F
    J Extra Corpor Technol; 2006 Sep; 38(3):216-9. PubMed ID: 17089507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of coated oxygenators in cardiopulmonary-bypass systems and their impact on neurocognitive function.
    Khosravi A; Skrabal CA; Westphal B; Kundt G; Greim B; Kunesch E; Liebold A; Steinhoff G
    Perfusion; 2005 Sep; 20(5):249-54. PubMed ID: 16231620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear cells during cardiac operations.
    Giomarelli P; Naldini A; Biagioli B; Borrelli E
    Int J Artif Organs; 2000 Apr; 23(4):250-5. PubMed ID: 10832659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do surface modifying additives (SMA) influence blood loss and thrombogenicity in conventional cardiopulmonary bypass for coronary artery bypass grafting?
    Martens S; Matheis G; Wimmer-Greinecker G; Scherer M; Doss M; Moritz A
    Cardiovasc Surg; 2003 Apr; 11(2):159-63. PubMed ID: 12664053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiopulmonary bypass technology transfer: musings of a cardiac surgeon.
    Rubens FD
    J Biomater Sci Polym Ed; 2002; 13(4):485-99. PubMed ID: 12160305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin.
    Harig F; Feyrer R; Mahmoud FO; Blum U; von der Emde J
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):111-8. PubMed ID: 10363611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated cardiopulmonary bypass circuits: current status.
    Hsu LC
    Perfusion; 2001 Sep; 16(5):417-28. PubMed ID: 11565897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circuits with surface modifying additive alter the haemodynamic response to cardiopulmonary bypass.
    Rubens FD; Ruel M; Lavallee G; Watson M; Robblee J; Wozny D; Nathan H
    Eur J Cardiothorac Surg; 1999 Mar; 15(3):353-8. PubMed ID: 10333035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery.
    McBride WT; Allen S; Gormley SM; Young IS; McClean E; MacGowan SW; Elliott P; McMurray TJ; Armstrong MA
    Cytokine; 2004 Jul 21-Aug 7; 27(2-3):81-9. PubMed ID: 15242697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active or passive bio-coating: does it matters in extracorporeal circulation?
    Jacobs S; De Somer F; Vandenplas G; Van Belleghem Y; Taeymans Y; Van Nooten G
    Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.